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1. Introduction 
Local anesthetics are drugs which possess the capac- 
ity to block to conduction of nerve action potentials 
by inhibiting changes in membrane sodium conduc- 
tance [ 11. They have a number of additional effects 
upon membrane structure and function as well. Local 
anesthetics can associate with both the lipids and 
proteins of cellular membranes [2-51, stabilize 
erythrocytes to osmotic shock [6-81, increase mem- 
brane volume [7], displace adsorbed calcium [7], 
inhibit membrane transport [9,10], decrease cell 
adhesiveness [1 11, inhibit cell fusion [ 121, and alter 
surface receptor mobility [ 13,141. 
A broad range of compounds with very different 
chemical structures possess local anesthetic activity. 
These include aromatic amines, butyrophenones, 
cyclohexanones, steroids, and phenothiazines [7]. 
~thou~ the rapid biophysics effects of local 
anesthetics upon nerve sodium conductance and 
erythrocyte membrane stabilization have been 
investigated in detail, little is known about their 
longer term effects upon the cellular metabolism of 
membrane molecules. Here we report that a variety 
of drugs with local anesthetic activity share the 
ability to inhibit cholesterol synthesis by rat C6 
glioma cultures. 
2. Materials and methods 
Rat Cb glioma cells (~e~can Type Culture Col- 
lection) were cultured in Eagle’s MEM plus 5% fetal 
calf serum and passaged atweekly intervals following 
dissociation with 0.25% trypsin containing 1 mM 
EDTA. 
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For [14C]acetate incorporation studies, cells were 
plated at 7.5 X lo4 cells/cm’ (-50% of confluency) 
in T75 tissue culture flasks 20 h prior to labeling. To 
initiate labeling, medium was changed and cultures 
subsequently incubated at 37°C in fresh medium con- 
taining [2-14C]acetate (55 mC!i/mmol; 0.5 PCijml). At 
the end of the labeling period, which was usually 6 h, 
medium was removed and the cell layers washed 3 
times with NKT (137 mM NaCl, 5.4 mM KCl, 1 mM 
Tris, pH 7.4) then scraped off with a rubber police- 
man and pelleted at low speed in a desk top centrifuge. 
Pellets were stored frozen at -20°C until use, then 
extracted with 2: 1 (v/v) c~orofo~-methanol, dried, 
and dissolved in 0.1 M NaOH for protein determina- 
tion by the Lowry method 1151. The chloroform- 
methanol extracts were dried under vacuum, redissolved 
in a small volume of chloroform-methanol, and 
cochromatographed with authentic neutral ipid stan- 
dards on silica gel G thin-layer plates in a solvent sys- 
tem consisting of benzene-diethyl ether-ethanol- 
water (50:40:2:0.2, by vol.), followed by diethyl 
ether-hexane (6:94, by vol.) [ 161. Approximately 
equal amounts of radioactivity were applied for each 
sample in a given experimental group. After chroma- 
tography, plates were exposed to iodine vapor to local- 
ize the lipid standards and then to Kodak Blue Brand 
X-ray film at -2O’C to localize radioactivity spots. Each 
spot was scraped from the thin-layer plate, hydrated 
with water, and counted in Triton X-toluene/PPOf 
POPOP (1:4, by vol.) in a Beckman liquid scintillation 
counter. In control cultures, all of the [ “C]acetate- 
derived radioactivity in the sterol fraction was present 
in desmosterol and cholesterol as determined by argen- 
tation chromatography [ 171. 
Adiphenine was the gift of Ciba-Geigy, and chlor- 
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promazine compounds were donated by Smith, Kline 
and French Labs. Ketamine was purchased from Bristol 
Labs., lidocaine from E&ins-Sinn, h~operidol from 
McNeil Lab., and tetracaine from Sigma. Lipid standards 
were purchased from Supelco and from Steraloids. 
3. Results 
Rat C6 glioma cells incorporate [2-‘4C]acetate into 
chloroform-methanol-extractable material at a con- 
stant rate for Z 7.5 h at 37’C (fig.1). After 6 h incu- 
bation with isotope, the sterol fraction (desmosterol 
plus cholesterol) of control cultures contains 4-13% 
of total extractable ra~oactivity. By contrast, when 
cultures are incubated with anesthetics during the 
labeling period, the entry of [14C]acetate into the 
sterol fraction is inhibited by 60-98% (fig.2,3). 
The reduction of [ 14C]acetate incorporation into 
the sterol fraction is accompanied by a redistribu- 
tion of the isotope into other lipid fractions. The 
nature of this redistribution varies with the anesthetic 
employed. For example, tetracaine, lidocaine, and 
pentobarbital divert the isotope flow primarily into 
the triglyceride and cholesterol ester fractions, while 
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Fig-l. Time course of f2-r4C)acetate incorporation into cellular 
lipids. C, glioma cultures labeled with 0.5 &i/ml [ 2-‘dC]aee- 
tate (55 mCi/mmol) were analyzed for protein content and 
chloroform-methanol extractable radioactivity at the times 
indicated. Protein content/dish remained at -0.1 mg during 
the labeling period. Values for duplicate samples were within 
10% of the average shown. 
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Fig.2. Inhibition of [ 2-14C]acetate incorporation into sterots 
by anesthetic oncentrations of drugs. Data is plotted as % 
of total lipid radioactivity present in sterols of control and 
drug-treated cultures. The results of 3 separate xperiments 
are shown. Cultures in the first experiment (c,h,p,k) were 
drug-treated for 30 h prior to labeling. The other 2 groups 
were drug-treated and labeled for 6 h. Abbreviations: c, 
control; h, haloperidol (10m4 M); p, Na-pentobarbital 
(10-a M); k, ketamine (10-s M); t, tetracaine (5 X 10e4 M); 
a, adiphenine (3 X lo-” M);l, lidocaine (2.5 X 10-s M); 
cp, chlorpromazine (1 O- * M). 
chlorpromazine diverts it into an unidentified lipid 
which migrates close to cholesterol on thin-layer 
plates (fig.3). 
The inhibition by anesthetics of [14C]acetate incor- 
poration into cholesterol and desmosterol appears to 
be a selective ffect. Even after 24 h drug treatment 
the incorporation into total chloroform-methanol- 
extractable material is not inhibited (data not shown). 
Moreover, with the possible xceptions of tetracaine 
and pentobarbital, none of the anesthetics which we 
employed ~hibited the synthesis of neutral ipids 
other than sterols. 
The inhibition of sterol synthesis by the local 
anesthetics develops within l-3 h after drug addition 
(fig.4). The effect is produced by anesthetic oncen- 
trations which are non-toxic even after 48 h continu- 
ous ~cubation. We have verified by electron micros- 
copy that cells treated with anesthetics are ultra- 
structurally normal, and differ from controls only in 
containing an elevated number of osmiophilic droplets 
which we presume contain lipids. 
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Fig.3. Autoradiographs of thin layers from experiments hown in fig.2. Abbreviations: CL, complex lipids; UL, unidentified lipid; 
CH, cholesterol plus desmosterol; TG, triglycerides; CHE, cholesteryl esters. 
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Fig.4. Time course of inhibition of [2-‘%]acetate incorpora- 
tion into sterols by lidocaine. The incorporation of [2-r%]- 
acetate into sterols was monitored at 1 h, 3 h and 5 h after 
addition of isotope (1 r&i/ml) to cultures which were simul- 
taneously exposed to growth medium minus drug (C, control) 
or to growth medium + 2.5 X lo-’ M lidocaine (L, + lido- 
Caine). The lipid extracts were chromatographed on thin 
layers and exposed to X-ray film, Results at 5 h were identical 
to those at 3 h. Desmosterol and cholesterol, the only sterols 
which are significantly labeled in gliomas, migrate as 1 band 
in this solvent system (indicated by the arrow). 
4. Discussion 
Current heories about he mech~isms of anesthesia 
have focussed primarily upon the biophysical conse- 
quences of anesthetic nteraction with membrane lipids 
and proteins. One hypothesis postulates that anesthetics 
act by producing localized phase changes inmembrane 
lipid domains [1 S-20]. A second hypothesis proposes 
that anesthetics act by direct association with amphi- 
pathic membrane proteins, altering their conforma- 
tion and biological activity 1211. 
This investigation demonstrates that anesthetics 
are potentially capable of altering membrane proper- 
ties by yet a third mechanism, one that is biochemical 
rather than biophy~c~ and involves the ~hibition of 
sterol synthesis. 
A variety of drugs which chemically and pharma- 
cologically are very different, but which all possess 
local anesthetic activity, were found to inhibit sterol 
synthesis by rat C6 glioma cells. Effective agents which 
we have tested include aromatic amines {adiphen~e, 
lidocaine, tetracaine), barbiturates ( odium pento- 
barbital), butyrophenones (haloperidol), cyclohexa- 
nones (ketamine) and phenothiazines (chlorpromazine) 
(figs). 
It is unclear at present whether these several drugs 
all act by the same or by different mechanisms. Cho- 
lesterol biosynthesis can be interrupted at multiple 
sites [22,23] and even drugs which are close structural 
analogs of one another can inhibit the pathway at 
different sites [24]. However, the mechanism(s) by
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F 
Udoorkla 
Fig.!& Structures of drugs used in this study. 
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which local anesthetics inhibit C6 sterol synthesis i  
selective in that [14C]acetate incorporation into total 
cellular lipids is unaltered. It is unlikely, therefore, 
that local anesthetics inhibit sterol synthesis by a 
general mechanism such as interference with acetate 
activation. 
The inhibition of sterol synthesis by the anesthetics 
does not appear to involve exclusively hydrophobic 
or polar interactions, ince drugs which interact with 
membranes in a predominantly hydrophobic manner 
(tetracaine and the phenothiazines) and drugs which 
interact in a predominantly polar manner (lidocalne) 
are both effective inhibitors [25-271. Further, inhib- 
itory activity is shown by drugs which are predomi- 
nantly charged at the pH employed in our experiments 
(pH 7.2) (aromatic amines) and by drugs which are 
predominantly unionized (pentobarbital). Thus the 
mechanism of action would not appear to depend 
upon whether a drug is charged or neutral. Inhibition 
is produced by molecules in which the polar amine 
moiety forms part of an aliphatic ring structure (halo- 
peridol), or is attached to an aliphatic ring (ketamine), 
or is contained in a flexible aliphatic hain of varying 
length and structure (lidocaine, tetracaine, adiphenine, 
chlorpromazine). 
The relative order of potency of anesthetics 
employed here in inhibiting C6 glioma sterol synthesis 
closely parallels that reported for their nerve conduc- 
tion blockage [6] and their osmotic stabilization of 
erythrocyte membranes [6-81 (table 1). 
The only obvious characteristic which all of these 
drugs have in common is their amphipathic structure. 
Not all amphipaths have anesthetic activity, however. 
Octanoic acid, a fatty acid which is reportedly devoid 
of anesthetic activity [28], also failed to inhibit cho- 
lesterol synthesis at 1.5 X 10m3 M, the lowest concen- 
Table 1 
Comparison of relative order of potency of anesthetics in nerve conduction 
blockage, protection of erythrocytes against hemolysis, and inhibition of C, 
glioma sterol synthesis 
Anesthetic Drug concentration (mol/l) required for 
Nerve blocka Antihemolysisb Sterol synthesis inhibitionC 
Chlorpromazine 
Haloperidol 
Chlorpromazine 
methiodide 
Tetracaine 
Adiphenine 
Na-pentobarbital 
Ketamme 
Lidocaine 
1 x lo-$ 2 x 10-s 0.5 x 1o-5 
2.2 x 10-s 2 x 10-S 
6 x lo-’ 5 x 10-s 
6.8 X 1O-5 5 x 1o-4 3 x 1o-5 
5 x 10-S 
1.7 x lo-” 3 x 1o-4 1 x 10-s 
1 x 10-s 
3.8 X 1O-3 1.8 X lo-’ 2.5 x 10-s 
a Minimum concentration for conduction blockage in frog sciatic nerve at 22°C [ 71 
b Concentration for 50% antihemolysis of human red blood cells assayed for 10 min 
101 
c The concentration for 50% inhibition of [ 2-Wlacetate incorporation into glioma 
sterols was determined by treating cell cultures with 4-5 concentrations of each 
drug, separating sterols from other neutral lipids by thin-layer chromatography, 
and quantitating isotope incorporation into sterols either by liquid scintillation 
counting of the thin layers (for lidocaine and chlorpromazine samples) or by 
comparing density of film exposure for drug-treated and control samples (all 
other drugs). Densities were ranked as f (little or no inhibition), ++ (50% inhibi- 
tion), +++ (75% inhibition) or ++++ (100% inhibition). Only one concentration 
was tested for Na-pentobarbital (lo- 3 M gave 60% inhibition) and for ketamine 
(10-s M gave 70% inhibition). The sensitivity of gliomas to drug inhibition of 
sterol synthesis varied with different batches of cells, but the relative potency 
order for drugs remained the same as shown in the table 
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tration which was non-toxic to gliomas. Thus, at the 
present time we suggest that whatever their molecular 
mechanism(s) of action might be, both a hydrophobic 
and polar moiety on a single molecule are required for 
the inhibition of cholesterol synthesis by anesthetic 
drugs. 
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